I now have sufficient information to compile a comprehensive response on UVR as a physiotherapy modality. Let me now synthesize everything.
Ultraviolet Radiation (UVR) - Complete Overview as a Therapeutic Modality
1. Introduction
UVR (Ultraviolet Radiation) is a form of electromagnetic radiation that occupies the portion of the spectrum between visible light (400 nm) and X-rays (100 nm). It is used in physiotherapy and dermatology as a therapeutic modality, primarily for skin conditions and wound healing.
UVR sits in the electromagnetic spectrum as follows:
Cosmic rays → X-rays → UVR (100-400 nm) → Visible light → Infrared → Microwaves → Radiowaves
2. Classification / Types of UVR
| Type | Wavelength | Common Name | Key Features |
|---|
| UVA | 400-315 nm | Near UV / Long-wave UV | Causes erythema, deep skin penetration, responsible for tanning/pigmentation, premature skin aging |
| UVB | 315-280 nm | Middle UV / Mid-wave UV | Causes erythema + pigmentation, Vitamin D synthesis, skin tanning (blistering/burn), most therapeutically active range |
| UVC | 280-100 nm | Far UV / Short-wave UV | Bactericidal action, kills bacteria, does not normally reach Earth's surface (absorbed by ozone) |
Note: UVB is the most biologically active and therapeutically important band in physiotherapy.
3. Sources / Production of UVR
Natural Source
- The sun - via heating of a body to incandescent temperature
Artificial Sources (Therapeutic)
Therapeutic UVR is produced by passing an electric current through ionized vapour - usually mercury vapour at low pressure or high temperature.
Types of lamps:
A. Air-Cooled Lamps (High-pressure mercury vapor)
- Example: Hanovia Alpine Sun Lamp
- Wavelength: ~253 nm (short wavelength)
- Emit UVR, infrared, and visible light
- UVR falls within UVB range
- Used for: generalized skin conditions (acne, psoriasis)
- Mainly produce erythema and photochemical reactions
- Tridymite formation - heat causes quartz tube to change to tridymite (another form of silica), which is opaque to UVR, causing output to fall; a variable resistance is included to increase potential difference and compensate
B. Water-Cooled Lamps (Low-pressure mercury vapor)
- Example: Kromayer Lamp
- Water jacket surrounds the burner with continually circulating water (removes heat/infrared)
- Delivers "cold UVR" - pure UVR without heat
- Can be used in contact with skin (wounds, body cavities)
- Wavelength: 253.7 nm (germicidal)
C. Fluorescent Tubes / Narrowband UVB
- Operate on same principle as gas discharge lamps
- Most commonly used today in phototherapy units
- Narrowband UVB (NB-UVB): 311-312 nm - most effective therapeutic wavelength
4. Physical Properties of UVR
UVR follows the same physical laws as other electromagnetic radiation:
- Reflection - reflected from smooth shiny surfaces
- Refraction - bends when passing through media of different optical density
- Absorption - absorbed by tissues; causes biological effects
- Penetration - limited penetration; UVC penetrates least, UVA penetrates deepest
Inverse Square Law: Intensity ∝ 1/d² (intensity decreases with square of distance)
Lambert's Cosine Law: Maximum intensity when rays are perpendicular to surface
5. Physiological / Biological Effects of UVR
Immediate Effects (Acute)
| Effect | Mechanism | Responsible Band |
|---|
| Erythema (Reddening) | Vasodilation - release of histamine, prostaglandins from damaged epidermal cells | UVB primarily |
| Pigmentation/Tanning | Oxidation of melanin (immediate darkening) + new melanin synthesis | UVA + UVB |
| Vitamin D Synthesis | 7-dehydrocholesterol → previtamin D3 in skin | UVB (290-315 nm) |
| Bactericidal effect | DNA damage to bacteria - thymine dimer formation | UVC (253.7 nm) |
| Desquamation | Shedding of superficial epidermal cells after higher doses | UVB |
Delayed / Chronic Effects
- Epidermal thickening - increased Malpighian layer (protective response)
- Decreased skin sensitivity after repeated exposure
- Premature skin aging (photoaging) - UVA-mediated collagen/elastin degradation
- Immunosuppression - depletion of Langerhans cells, altered antigen presentation, regulatory T-cell expansion
- DNA mutations - UV signature mutations (C→T and CC→TT transitions), particularly in SCC and melanoma
- Skin cancer - risk of BCC, SCC, and melanoma with chronic exposure
6. Erythema Reactions / Dosimetry
Minimal Erythema Dose (MED)
The MED is the smallest dose of UVR that produces a uniform, just perceptible erythema over the entire exposed area, read at 24 hours post-exposure.
Erythema Grades (E-doses)
| Grade | Appearance | Onset | Duration | Equivalent |
|---|
| E1 (Sub-erythema dose - SED) | No visible reddening | - | - | Photochemical effects only |
| E2 (Minimal erythema dose - MED / 1st degree) | Faint erythema, no tenderness | 6-8 hrs | 24 hrs | Just perceptible redness |
| E3 (2nd degree / E2 × 2.5) | Definite erythema, slight tenderness | 4-6 hrs | 2-3 days | Moderate redness |
| E4 (3rd degree / E3 × 5) | Intense erythema, oedema, tenderness | 2-4 hrs | 3-5 days | Blistering possible |
| E5 (4th degree / E4 × 10) | Extreme erythema, blistering, vesiculation | 1-2 hrs | 7+ days | Severe burn |
Dosimetry Protocols (from Fitzpatrick's Dermatology)
MED Testing Method:
- Expose 1 cm² areas on inner forearm or lower back
- NB-UVB: doses of 200, 400, 600, 800, 1000, 1200 mJ/cm²
- BB-UVB: doses of 20, 40, 60, 80, 100, 120 mJ/cm²
- Read at 24 hours
- Start treatment at 50-70% of MED
Subsequent Treatments:
- Given 2-5 times per week
- Increase dose by 10-20% each session (NB-UVB) or 25% for first 10 treatments then 10% (BB-UVB)
- 70/20 Rule (general): Start at 70% MED, increase by 20% each successive treatment
NB-UVB Starting Doses by Fitzpatrick Skin Type:
| Skin Type | Initial Dose (mJ/cm²) | Maximum Dose (mJ/cm²) |
|---|
| I | 130 | 2000 |
| II | 220 | 2000 |
| III | 260 | 3000 |
| IV | 330 | 3000 |
| V | 350 | 5000 |
| VI | 400 | 5000 |
7. Therapeutic Indications (Uses)
Primary / Dermatological Uses
| Condition | Treatment Rationale |
|---|
| Psoriasis | Decrease DNA synthesis in skin cells; BB-UVB, NB-UVB, or PUVA (psoralen + UVA) |
| Acne Vulgaris | Desquamation opens blocked pores and hair follicles; E2 dose to face, chest, neck |
| Eczema / Atopic dermatitis | Anti-inflammatory and immunosuppressive effects |
| Vitiligo | Stimulate repigmentation of depigmented areas |
| Mycosis fungoides (cutaneous T-cell lymphoma) | PUVA and NB-UVB |
| Parapsoriasis | Phototherapy |
| Pityriasis rosea | Speed resolution |
| Seborrheic dermatitis | Anti-inflammatory/desquamation |
| Wound healing (chronic ulcers) | Bactericidal UVC effect; stimulate wound healing |
PUVA (Photochemotherapy)
- Psoralen + UVA combination
- Psoralens (photosensitizing drugs) intercalate into DNA and crosslink with UVA irradiation
- Highly effective for psoriasis, vitiligo, CTCL
8. Contraindications
Absolute Contraindications
- Photosensitivity disorders (e.g., lupus erythematosus, polymorphous light eruption, xeroderma pigmentosum)
- Active tuberculosis (skin TB)
- Skin cancer / history of skin cancer
- Pellagra (niacin deficiency - photosensitive)
- Porphyria
- Acute eczema / dermatitis (active inflamed phase)
- Febrile conditions
- Radiation therapy - irradiated areas
Relative Contraindications / Precautions
- Photosensitizing drugs (tetracyclines, sulfonamides, phenothiazines, NSAIDs) - increase sensitivity dramatically
- Hyperthyroidism (increased sensitivity)
- Renal/hepatic disease (impaired metabolism)
- Pregnancy (caution)
- Previous extensive UVR treatment (cumulative cancer risk)
- Eye exposure - strong doses of UVB/C to eyes can cause photokeratitis (arc eye) - protective goggles mandatory
9. Treatment Technique / Application
Pre-Treatment Assessment
- Skin type assessment (Fitzpatrick I-VI)
- MED determination
- Test dose if uncertain
- Identify photosensitizing medications
Application Steps
- Warm-up lamp - allow 5-10 minutes for full output
- Protect eyes with UV-opaque goggles (patient and therapist)
- Expose area - position at correct distance (usually 30-90 cm depending on lamp)
- Time the exposure precisely
- Cover surrounding skin if treating localized area
- Document: dose (mJ/cm²), distance, duration, skin response
Distance-Dose Relationship
Using inverse square law: if distance doubles, intensity reduces to 1/4; compensate by quadrupling time.
10. Dangers / Side Effects of UVR
| Effect | Detail |
|---|
| Sunburn (severe erythema) | Overexposure - blistering, vesiculation |
| Photokeratitis | "Arc eye" - UVB/C to unprotected eyes |
| Cataracts | Chronic UV exposure to eyes |
| Photoaging | Premature wrinkling, elastosis (UVA) |
| Immunosuppression | Depletion of skin-resident immune cells |
| Skin cancer | BCC, SCC, melanoma - with chronic cumulative exposure (particularly UVB-induced DNA mutations) |
| Photosensitivity reactions | Drug interactions |
11. Summary Table
| Parameter | Detail |
|---|
| Spectrum | 100-400 nm (between X-ray and visible light) |
| Types | UVA (315-400), UVB (280-315), UVC (100-280) |
| Therapeutic source | Mercury vapor lamps, fluorescent NB-UVB tubes |
| Main therapeutic band | UVB (especially NB-UVB 311 nm) |
| Key measurement | MED (Minimal Erythema Dose) |
| Primary indications | Psoriasis, acne, eczema, vitiligo, wound healing |
| Key contraindication | Photosensitivity, skin cancer, lupus |
| Eye protection | Always required (UV-opaque goggles) |
References:
- Fitzpatrick's Dermatology, Vol. 1&2 - Phototherapy protocols and NB-UVB dosing tables (p. 3670)
- Dermatology 2-Volume Set 5e - UVR and melanoma risk
- UVR physiotherapy notes - Sreeraj SR - Apparatus, erythema grades, indications
- UVR dose models review - Dosimetry and clinical implementation